Senores Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2026 ,inter alia, to consider and approve to consider and approve ....

Date: July 21, 2026 To, To, Sr. General Manager Sr. General Manager BSE Limited National Stock Exchange of India Limited Listing Department Listing Department Phiroze Jeejeebhoy Towers Exchange Plaza, C-1, Block G Dalal Street Bandra Kurla Complex Mumbai – 400 001 Bandra (E), Mumbai – 400 051 BSE Scrip Code: 544319 NSE Symbol: SENORES DSuebar.: SIinrt/iMmaadtaiomn, of Board Meeting scheduled to be held on Monday, July 27, 2026 Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a meeting of the Board of Directors of Senores Pharmaceuticals Limited (the “Company”) is scheduled to be held on Monday, July 27, 20 26 inter alia, to: 1. Consider and approve the Unaudited Consolidated and Standalone Financial Results of the Company for the quarter ended June 30, 2026; and 2. To transact other business matters. Further, in this connection, please refer our earlier intimation dated June 26, 2026, whereby, pursuant to the Company’s Code of Conduct framed in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 as amended (“the Code”), the Trading Window for dealing in securities of the Company, for persons specified under the Code, was closed from July 01, 2026 till 48 hours after the Unaudited Consolidated and Standalone Financial Results of the Company for the quarter ended June 30, 2026 are approved by the Board of Directors and submitted to Stock Exchanges. You are requested to take the same on record. TFohra nSkeinnogr yeosu P. harmaceuticals Limited Deval Rajnikant Shah Whole-Time Director & CFO DIN: 00332722 Senores Pharmaceuticals Limited 1101 to 1103, 11th Floor, South Tower, One42, Opp. Jayantilal Park, Ambali Bopal Road, Ahmedabad-380054, Gujarat, India P: +91 79 2999 9857 | E: info@senorespharma.com W: www.senorespharma.com | CIN No.: L24290GJ2017PLC100263